Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Bharat Biotech failed to halt clinical trials after one person developed serious side-effects during the testing of Covaxin, its indigenously developed Covid-19 vaccine candidate. Dr. Srinath Reddy, President of Public Health Foundation of India, and ET’s Teena Thacker take us through the protocols and challenges of developing a vaccine.
See omnystudio.com/listener for privacy information.